The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


Sanofi PasteurEU/1/20/1483/001-002

Main Information

Trade NameMenquadfi
Active SubstancesNeisseria Meningitidis Group A Polysaccharide
Neisseria Meningitis Group W135 Polysaccharide
N. Meningitidis Group Y Polysaccharide
Tetanus toxoid
N. Meningitidis Group C Polysaccharide
Dosage FormSolution for injection
Licence HolderSanofi Pasteur
Licence NumberEU/1/20/1483/001-002

Group Information

ATC CodeJ07AH08 meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated


License statusAuthorised
Licence Issued18/11/2020
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back